3983 results about "Polymer particle" patented technology

The invention provides particle compositions having applications in nucleic acid analysis. Nucleic acid polymer particles of the invention allow polynucleotides to be attached throughout their volumes for higher loading capacities than those achievable solely with surface attachment. In one aspect, nucleic acid polymer particles of the invention comprise polyacrylamide particles with uniform size distributions having low coefficients of variations, which result in reduced particle-to-particle variation in analytical assays. Such particle compositions are used in various amplification reactions to make amplicon libraries from nucleic acid fragment libraries.

The present invention provides systems, methods, and compositions for targeted delivery of nanoparticles and / or agents to tissues, cells, and / or subcellular locales. In general, compositions comprise a nanoparticle (e.g. quantum dot, polymeric particle, etc.), at least one modulating entity (such as a targeting moiety, transfection reagent, protective entity, etc.), and at least one agent to be delivered (e.g. therapeutic, prophylactic, and / or diagnostic agent). The present invention provides methods of making and using nanoparticle entities in accordance with the present invention.

Apparatuses and methods are described that involve the deposition of polymer coatings on substrates. The polymer coatings generally comprise an electrically insulating layer and / or a hydrophobic layer. The hydrophobic layer can comprise fused polymer particles have an average primary particle diameter on the nanometer to micrometer scale. The polymer coatings are deposited on substrates using specifically adapted plasma enhanced chemical vapor deposition approaches. The substrates can include computing devices and fabrics.

Absorbent articles and processes for making absorbent articles are provided. The process includes spraying onto a fibrous web a blend containing superabsorbent polymer particles, superabsorbent forming monomer, initiator and water, and subjecting the web to polymerization conditions. The resulting web is useful as an absorbent article particularly in disposable hygiene products.

The present invention concerns polymer particle vaccine delivery systems in which a water insoluble protein antigen, e.g. a lipidated HpaA protein, is incorporated with particles comprising a polymer matrix. The present invention also concerns a method for incorporating such a water insoluble protein antigen with a polymer matrix in order to produce a polymer particle vaccine delivery system. In addition, the invention also provides a vaccine composition comprising the polymer particle delivery system. The vaccine can be used to treat and / or reduce the risk of for example Helicobacter infection.

A particulate material composition of superabsorbent polymer particles, wherein less than about 60% by weight of the superabsorbent polymer particles will pass through a U.S. Standard 50 mesh sieve. The composition has anti-caking properties and also reduced dusting. The composition can be produced by mixing the superabsorbent polymer particles with an inorganic powder, such as clay.

This invention relates to a method of forming a polymer component and comprises blending polymer particles with antioxidant to form a mixture in which the antioxidant coats the polymer particles, irradiating the mixture to cross-link the polymer particles therein and forming the irradiated mixture into a consolidated component. The invention also relates to a method of forming an articular surface for a prosthesis and a prosthesis having a polymer articular bearing surface wherein at least one pre-determined portion of the bearing surface is provided with cross-linked polymer bonds.

An improved method of making a series of bead or microsphere or particle populations characterized by subtle variation in a proportion or ratio of at least two fluorescent dyes distributed within a single bead of each population is provided. These beads, when excited by a single excitation light source are capable of giving off several fluorescent signals simultaneously. A set containing as many as 64 distinct populations of multicolored, fluorescent beads is provided and when combined with analytical reagents bound to the surface of such beads is extremely useful for multiplexed analysis of a plurality of analytes in a single sample. Thus, methods of staining polymeric particles, the particles themselves, and methods of using such particles are claimed.

The present invention provides biodegradable polymer particle delivery compositions for delivery of macromolecular biologics, for example in crystal form, based on polymers, such as polyester amide (PEA), polyester urethane (PEUR), and polyester urea (PEU) polymers, which contain amino acids in the polymer. The polymer particle delivery compositions can be formulated either as a liquid dispersion or a lyophilized powder of polymer particles containing bound water molecules with the macromolecular biologics, for example insulin, dispersed in the particles. Bioactive agents, such as drugs, polypeptides, and polynucleotides can also be delivered by using particles sized for local, oral, mucosal or circulatory delivery. Methods of delivering a macromolecular biologic with substantial native activity to a subject, for example orally, are also included.

The present invention relates to a process for the manufacture of metal-containing materials or composite materials, the process comprising the steps of encapsulating at least one metal-based compound in a polymeric shell, thereby producing a polymer-encapsulated metal-based compound and / or coating a polymeric particle with at least one metal-based compound; forming a sol from suitable hydrolytic or non-hydrolytic sol / gel forming components; combining the polymer-encapsulated metal-based compound and / or the coated polymeric particle with the sol, thereby producing a combination thereof; and converting the combination into a solid metal-containing material. The present invention further relates to metal-containing materials produced in accordance with the above process.

Hollow thermoexpandable particles or microspheres are provided that contain hydrocarbon blowing agents and have a shell polymer that can be softened at the onset of the expansion temperature and solidified at a higher temperature (thermoset) in an expanded state. Preferably, the microspheres have a shell of thermally expandable and thermally crosslinkable polymer and a hollow interior that contains a hydrocarbon liquid that boils at a temperature below the heat activated crosslinking temperature of the polymer shell. The crosslinking of the shell polymer during or after expansion, which is heat activated at an elevated temperature, can solidify the shell polymer and, then, maintain the expanded volume of the microspheres. The thermoexpandable thermoset polymer particles are useful in insulation, packaging, for making foam materials such as polyurethane or polyisocyanurate rigid foams. The invented thermoset microspheres can substantially improve the close cell percentage and compressive strength of the foam materials and make the foam manufacturing less hazardous.

The present invention provides synthetic vaccines against a variety of pathogenic organisms and tumor cells in humans and other mammals based on biodegradable polymers containing polyester amide (PEA), polyester urethane (PEUR), and polyester urea (PEU) and immunostimulatory adjuvants. The vaccines can be formulated as a liquid dispersion of polymer particles or molecules in which are dispersed an immunostimulatory adjuvant, such as a TLR agonist, and whole protein or peptidic antigens containing MHC class I or class II epitopes derived from organism or tumor cell proteins. Methods of inducing an immune response via intracellular mechanisms to the pathogenic organism or tumor cells specific for the antigen in the invention compositions are also included.

A drug delivery system comprising pH triggerable particles is described. The pH triggerable particles comprise and agent(s) to be delivered, which is encapsulated in a matrix comprising a pH trigger agent and a polymer. Agents including nucleic acids may be delivered intracellularly using the inventive pH triggerable particles. Upon exposure to an acidic environment such as the endosome or phagosome of a cell, the particles dissolve or disrupt due to protonation or an increase in solubility of the pH triggering agent. Pharmaceutical compositions and methods of preparing and administering these particles are also described. These particles may be particularly useful in genetic vaccination.

This invention is directed to super-absorbent material, which comprises a super absorbent polymer core that is coated with an organic, polar coating agent, and whereby the particulate super-absorbent material has a contact angle and a corresponding cos CAm (as defined herein), whereby the cos CAm is more than 0.3, and whereby, when said coating agent is in the form of particles, said coating agent particles have a (weight) mean particle size of from 0.001 to 1 micron. The material is useful for absorbent structures and absorbent articles (comprising such structures). The coated super-absorbent material is typically present in said absorbent structure at least at a concentration of 50% by weight of the structure, preferably even 80% or even 90%. The invention also provides a process for making the absorbent material.

A method and apparatus for underwater pelletizing and subsequent drying of polyethylene terephthalate (PET) polymers and other high temperature crystallizing polymeric materials to crystallize the polymer pellets without subsequent heating. High velocity air or other inert gas is injected into the water and pellet slurry line to the dryer near the pelletizer exit. Air is injected into the slurry line at a velocity of from about 100 to about 175 m3 / hour, or more. Such high-speed air movement forms a vapor mist with the water and significantly increases the speed of the pellets into and out of the dryer such that the PET polymer pellets leave the dryer at a temperature sufficient to self-initiate crystallization within the pellets. A valve mechanism in the slurry line after the gas injection further regulates the pellet residence time and a vibrating conveyor after the dryer helps the pellets to achieve the desired level of crystallinity and to avoid agglomeration.

This present invention provides devices for the parallelization of the formation of droplets in a multiple droplet generator integrating two or more parallel flow-focusing devices (FFDs) with either identical, or different, geometries. In the parallel identical FFDs, emulsification generates droplets with a narrow (below 4%) polydispersity despite weak coupling between the identical flow-focusing devices. Formation of droplets in the integrated droplet generator comprising FFDs with different dimensions of the microchannels occurs with strong coupling between the FFDs and produces droplets with varying sizes and size distributions. For such devices the regime in which emulsification produces droplets with varying dimensions and a narrow size distribution have been identified. The results of this work can be used in scaling up the production of droplets and in the simultaneous production of droplets and particles with different dimensions.

This invention provides a catalys conponent and catalyst. Said catalyst comprises titanium, magnesium and at least three electron donor compounds a, b and c, in which is selected from mono-aliphatic-carboxylate or mono-aromatic-carboxylate compounds, b is selected from a special diatomic alkoxide compound, and c is selected from binary binary-aliphatic-carboxylate or binary-aromatic-carboxylate or b is ether compound. Advantages: high polymerization activity and stereospecificity when used for olefin polymerization, in particular for propylene polymerization, wide molecular weight distribution of obtained polymer and good shape of polymer granulars.

Formulations or delivery systems are provided for controlled release of therapeutically active agents. The delivery systems are composed of polymer and lipid materials and may be prepared as a gel, paste, solution, film, implant or barrier depending on the intended application. The polymer component of the matrix is the naturally occurring biomaterial, chitosan, or a mixture of chitin and chitosan. The lipid component may include phosphatidylcholine, phosphatidylserine, phosphatidylinositol, phosphatidyl or a mixture thereof. The delivery system may be used for delivery of hydrophilic agents, hydrophobic agents or combinations thereof. The therapeutically active agents may be formulated within the matrix as free agents or incorporated into particles. In a preferred embodiment the agents are incorporated into polymeric particles that are dispersed throughout the matrix.

A monomer for a shell or a mixture of at least two monomers for a shell was suspension polymerized in the presence of core particles and a polymerization initiator to obtain polymer particles, wherein said core particles are formed of a polymer obtained by polymerization of a monomer for a core or a mixture of at least two monomers for a core and containing a colorant, wherein said monomer for a shell or mixture of monomers for a shell is one which gives upon polymerization a polymer having a glass transition temperature higher than that of the polymer forming the core particle, and wherein said polymerization initiator is represented by the following formula 1: wherein X1, X2, X3 and X4 independently represent oxygen atom, sulfur atom, >NR (wherein R is hydrogen atom, alkyl group, or group); R1, R2, R3, R4, R5 and R6 independently represent alkyl group, aryl group, or alkyl or aryl group having at least one substituent which is -OR, -OH, -NHR, or -NR2(wherein R is alkyl group or aryl group), and n and m independently represent an integer of 1 to 10. An outer additive was applied on the polymer particle to obtain a polymerized toner. This polymerized toner has low fixing temperature, excellent overhead projector transparency, good shelf stability, and exhibiting a less pronounced reduction in electric charge under conditions of high humidity and high temperature.

A hydrogel polymer obtained by polymerizing a monomer component including acrylic acid (salt) is post-neutralized so that each of polymer particles derived from a polymer produced by neutralizing the hydrogel polymer has an allowable neutralization ratio. The polymer as obtained by neutralizing the hydrogel polymer is reacted with a crosslinking agent reactive to a functional group of the polymer. The allowable neutralization ratio, for example, is a neutralization ratio which is not lower, by not less than 20 mole percent, or more than, at least 55 mole percent, than an average neutralization ratio of a mass of the polymer particles, and the post-neutralization is carried out so that a number of polymer particles having a non-allowable neutralization ratio outside the allowable neutralization range is not more than 10 in 200 polymer particles, thus obtaining a water-absorbent agent having high absorbency under no applied pressure and high pressure wherein the amount of water soluble component is lower compared with the conventional water-absorbent agent and a change in pH of a swollen gel is small.